Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
overall Survival
May 2007
Yes
Cyrille Hulin, MD
Principal Investigator
Hematology CHU Nancy and Intergroupe Francophone du Myelome (IFM)
France: French Agency of Health Security and Drugs Products
University Hospital, Nancy
NCT00644306
April 2002
May 2007
Name | Location |
---|